Canopy Growth (WEED) has been aggressively pursuing its expansion strategy to capture the recreational cannabis market in Canada as well as medical cannabis in various parts of the world. In its recent MD&A (Management Discussions and Analysis), the company stated that it has increased its footprint in six Canadian provinces as well as six countries.
Canopy Growth aims to be a multi-brand mover of cannabis and has acquired several companies along the way. In the above chart, we can see a partial list of brands under the company’s subsidiary.
In its recent MD&A released in February 2018, the company listed 18 subsidiaries in which it has ownership or jointly controls the operations. Some of the names include Tweed, Bedrocan Canada, Spectrum Brands, Mettrum Hempworks, and Canopy Rivers.
The company also listed ten investments in affiliates, including Agripharm, AusCann, Vapiam, and TerrAscend.
Most of the subsidiaries operate in Canada, but Canopy Growth’s investments in companies such as AusCann are intended to help penetrate the Australian market.
MedReleaf (MEDFF) has a similar venture partner in Australia, Indica Industries, which will produce medical cannabis. MedReleaf has a 10% equity interest in its Australian partner. Later, we’ll see how Cronos Group (CRON) has also expanded into the Australian market.
Most of the companies provide cannabis-related products. While these companies (HMMJ) currently provide cannabis for medical use, some will also provide it for non-medical use when it becomes legal in Canada.